| Date | Title | Description |
| 04.01.2024 | Is There a New Leader Rising in Global Healthcare and Biotechnology Industry? | Key Takeaways:
Covidien, a Dublin-based healthcare start-up is emerging as a global leader in the industry.
They offer an array of products across Medical Devices, Imaging Solutions, Pharmaceutical Products and Medical Supplies segments.
Th... |
| 21.04.2015 | Niche and 'tech' brands create compelling web content | Niche and 'tech' brands create compelling web content
21-04-2015
Your business may not be mainstream or trendy, but you can still enjoy the benefits of marketing using good web content.
Red Ruby Copywriting writes:
Being ‘cool’ certainly is... |
| 22.01.2015 | Covidien’s Q1 earnings top estimates | Covidien (NYSE:COV) today reported fiscal 1st-quarter earnings that topped expectations on Wall Street, just a week before its pending $43 billion merger with Medtronic (NYSE:MDT) is slated to close.
Mansfield, Mass.-based Covidien posted p... |
| 09.01.2015 | Covidien’s Stellarex drug-eluting balloon wins CE Mark | European regulators granted market clearance for Covidien‘s (NYSE:COV) Stellarex drug-eluting balloon for treating peripheral artery disease, the company said today.
Covidien is due to sell the Stellarex assets to Spectranetics (NSDQ:SPNC) ... |
| 06.01.2015 | FLASH: Covidien shareholders approve Medtronic merger | Covidien (NYSE:COV) said this morning that shareholders voted to approve its pending, $43 billion merger with Medtronic (NYSE:MDT) at a meeting in Ireland.
It’s a penultimate step in consummating the union, announced last summer, as Medtron... |
| 30.12.2014 | These 8 digital health M&A deals stood out in 2014 | Box acquired MedXT‘, a medical imaging company designed to speed up the way radiology images are shared by improving interoperability. Hospitals represent the fastest growing part of the cloud storage business. It also offers an example of ... |
| 17.12.2014 | Mr. Clean: Device makers jump on positive thrombectomy results in stroke trial | Medical device makers today were quick to jump on the bandwagon after the New England Journal of Medicine today published study results showing that new-generation thrombectomy devices were superior in treating severe ischemic strokes than ... |
| 24.11.2014 | Covidien wins FDA nod for Fortrex PTA balloon catheter | Covidien (NYSE:COV) said today that it won 510(k) clearance from the FDA for its Fortrex balloon catheter, which is designed both for maintaining arteriovenous access for hemodialysis and for treating peripheral artery disease.
Mansfield, M... |
| 17.11.2014 | Covidien study: VenaSeal effective in treating leg veins | Covidien (NYSE:COV) touted a study showing that its VenaSeal system is just as effective in treating chronic leg vein disorders as its ClosureFast ablation catheter.
The randomized study, called VeClose, tracked 242 patients undergoing trea... |
| 05.11.2014 | Covidien beats with fiscal Q4, 2014 results | Covidien (NYSE:COV) handily beat analysts’ expectations for its fiscal 4th-quarter and full-year results this morning, topping earnings-per-share forecasts with Q4 profit growth of 39%.
Covidien reported profits of $517 million, or $1.13 pe... |
| 04.11.2014 | Covidien wins FDA nod for HawkOne atherectomy device | Covidien (NYSE:COV) said today that the FDA granted 510(k) clearance for the latest addition to its line of atherectomy devices, the HawkOne directional system for peripheral artery disease.
"Covidien is committed to being the clear fi... |
| 01.11.2014 | Boulder County area’s largest employers in the private sector | 1.) IBM Corp.
Address: 6300 Diagonal Highway, Boulder, 80301
Phone: 303-924-6300
Website: ibm.com
Stock exchange/symbol: NYSE/IBM
Full-time employees in Boulder County region: 2,800 (estimate)
Part-time employees in Boulder County region: N... |
| 27.10.2014 | Covidien unveils next-gen superDimension device | Covidien (NYSE:COV) today unveiled the next generation of its superDimension navigation software for lung procedures.
The technology, an electromagnetic navigation bronchoscope, is used to diagnose pulmonary diseases like emphysema, cancer ... |
| 23.10.2014 | Survey: Stroke still a mystery to many | Despite stroke being the 2nd leading cause of death worldwide, many people still do not recognize risk factors and warning signs, according to a poll sponsored by Covidien (NYSE:COV) and the World Stroke Organization.
The online survey in e... |
| 17.10.2014 | Covidien wins injunction against J&J unit’s surgical shears | Covidien (NYSE:COV) won a round this week in its long-running set-to with Johnson & Johnson‘s (NYSE:JNJ) Ethicon Endo-Surgery division over surgical instrument patents when a federal judge in Connecticut granted an injunction barring sa... |
| 10.10.2014 | FDA OKs Covidien’s Nellcor portable oxygen monitor | The FDA gave the green light to Covidien‘s (NYSE:COV) Nellcor portable SpO2 monitor, which is used to monitor oxygen and pulse levels in the home.
The Nellcor device can be used to monitor adults and babies at risk for respiratory distress ... |
| 02.10.2014 | Analyst: Edwards Lifesciences’ Sapien 3 poised to lead TAVI market | MassDevice.com On Call | MASSDEVICE ON CALL — Edwards Lifesciences (NYSE:EW) is poised to take the lead in the transcatheter aortic valve market with its Sapient 3 replacement heart valve, according to Leerink Partners analyst Danielle Antalffy.
Writing yesterday i... |
| 28.08.2014 | Covidien acquires Sapheon and its VenaSeal varicose vein treatment | Covidien (NYSE:COV) continued the acquisition spree by it and Medtronic (NYSE:MDT) ahead of their blockbuster merger today, announcing the 4th acquisition since news of their $43 billion union broke last June.
Covidien said it paid an undis... |
| 22.08.2014 | Covidien snaps up Reverse Medical | Covidien (NYSE:COV) isn’t letting its impending acquisition by Medtronic (NYSE:MDT) slow down its own merger activity, announcing today that it acquired Reverse Medical and its line of vascular devices for an unspecified amount.
The move ad... |
| 21.08.2014 | FDA OKs return of Covidien’s Pipeline embolism device | Covidien (NYSE:COV) said today that an FDA clearance means it can get its Pipeline brain embolism device back on the U.S. market immediately, nearly 5 months after a voluntary recall of the Pipeline coil and the Alligator retrieval device.
... |
| 21.08.2014 | Covidien opens Brazilian training center | MassDevice.com On Call | MASSDEVICE ON CALL — Medtech titan Covidien (NYSE:COV) cut the ribbon on a new training center in Sao Paulo, Brazil, the home country of president & CEO Jose Almeida.
The company said that the new 3,000-square meter facility is located ... |
| 20.08.2014 | Covidien’s atherectomy study finally hits JACC | It may have taken 2 years but final results from Covidien’s (NYSE:COV) DEFINITIVE LE study finally appeared in the Journal of the American College of Cardiology’s Cardiovascular Interventions issue.
Originally announced in 2012, the results... |
| 25.07.2014 | Covidien’s Q3 sales meet The Street, earnings top estimates | Covidien (NYSE:COV) said today that its fiscal 3rd-quarter earnings topped expectations on Wall Street, on sales that came in dead even with analysts’ consensus estimate.
Mansfield, Mass.-based Covidien posted profits of $306 million, or 67... |
| 22.07.2014 | Covidien promotes Hanson to group president role | Personnel Moves | Covidien (NYSE:COV) said today that it promoted its medical device unit’s president, Bryan Hanson, to be group president effective Oct. 1.
The new title gives Hanson oversight of all Covidien’s businesses, according to a press release.
&quo... |
| 16.07.2014 | Covidien to launch Emprint soft tissue ablation device | Covidien (NYSE:COV) said today that it’s launching its Emprint soft tissue ablation system, aiming at the market for inoperable liver cancers.
The Mansfield, Mass.-based medical device company said the Emprint device, which uses Covidien’s ... |
| 24.06.2014 | Covidien’s next-gen Pipeline embolization lands in Europe | Medtech giant Covidien (NYSE:COV) announced this week that it’s prepared to launch its Pipeline Flex embolization devices in Europe.
The device has CE Mark indication for treating cerebral aneurysms via endovascular embolization. The origin... |
| 24.06.2014 | Covidien levels another lawsuit at Ethicon Endo over ultrasound shears | Covidien (NYSE:COV) yesterday leveled another patent infringement lawsuit against Johnson & Johnson‘s (NYSE:JNJ) Ethicon Endo-Surgery division, alleging that the latest iteration in Ethicon’s ultrasound surgical shears infringes 3 Covid... |
| 11.06.2014 | Press Release: Covidien Neurovascular Micro Catheter Receives FDA Approval | DUBLIN, Ireland — Covidien plc (NYSE: COV) today announced U.S. Food and Drug Administration (FDA) approval of its Apollo™ Onyx™ delivery micro catheter – the first detachable tip micro catheter available in the U.S. The new micro catheter ... |
| 03.06.2014 | Press Release: Covidien Announces CE Mark of Nellcor™ Respiration Rate Technology | DUBLIN, Ireland–Jun. 3, 2014– Covidien plc, a leading global provider of health care products and recognized innovator in patient monitoring and respiratory care devices, today announced the European commercial launch of its Nellcor™ Respir... |
| 05.05.2014 | Covidien makes wearables acquisition with Zephyr Technology deal | “The total consideration was comprised of upfront cash payments totaling $94 million ($92 million, net of cash acquired); debt assumed of $1 million, which was subsequently repaid; and the fair value of contingent consideration of $33 milli... |
| 09.04.2014 | Emerging medtech margins: Don’t think price, think COGS | By Tim Kofol, S2N Health
Fact: the prices of medical devices, whether innovative or commodity, are under significant pressure from all corners and in all parts of the globe, and will continue to be for the foreseeable future. Fact: whether ... |
| 28.02.2014 | Still in the renal denervation space? Startups, consider adaptive trial design, CRO says | For instance, if a sub-population of patients seems to respond with much more efficacious outcomes than the whole population early on, the trial can be adjusted to focus just on those patients.
For startups, Dentry-Mabry said, it can be att... |
| 27.02.2014 | Covidien closes $860M Given Imaging buy | Covidien (NYSE:COV) said it closed the buyout of Given Imaging and its PillCam imaging device for about $860 million, net of cash and investments.
The $30-per-share price is a nearly 27% premium over Given Imaging’s $23.65 closing price Dec... |
| 16.01.2014 | Covidien closes $235M divestiture of Confluent to Integra LifeSciences | Covidien (NYSE:COV) this week consummated the divestiture of its Confluent Surgical line of surgical sealants and shields, handing the unit over to Integra LifeSciences(NSDQ:IART) in a deal worth up to $265 million.
Integra LifeSciences pai... |
| 09.01.2014 | FIRE1 Raises Series A Funding | FIRE1, a Dublin, Ireland-based developer of novel therapeutic devices, raised a Series A funding of undisclosed amount.
The company is incubated within The Foundry, a medical device incubator.
Backers included Covidien plc (NYSE: COV), Ligh... |
| 09.12.2013 | The Maker of a Swallowable Pill That Takes Pictures Sells for $860 Million | December 9, 2013 1 min read
It's not just your photo-snapping smartphone that's a hot commodity these days.
Israel-based Given Imaging, the maker of a swallowable pill camera called PillCam, agreed to be purchased by Dublin-based Covidien f... |
| 24.09.2013 | Sub-Saharan Africa: ‘perhaps the next frontier’ for medical device industry, says Covidien CEO | During the discussion, he pointed to Brazil’s protests–which include demands for better healthcare–as an indicator of how innovation is driven.
“If you think about access to healthcare as what drives healthcare innovation, I think the drive... |
| 30.08.2013 | Value, VCs and international markets: One industry leader’s answers on where medtech fits in | How is value changing for the medtech industry in this time of healthcare reform?
Broad sweeping healthcare reform including accountable care has led hospitals and physicians to struggle to find avenues to cut costs and improve efficiency, ... |
| 05.04.2013 | Are healthcare accelerators producing stronger startups? | A member of Blueprint’s previous class, Medikly, raised $1.2 million to expand its service aimed at the pharmaceutical industry to help marketers find their target physician and nurse audience on social media. It is led by Dr. Venkat Gullap... |
| 08.03.2013 | Hernia: Covidien’s biologic mesh product hits a wall | Covidien’s (NYSE:COV) biologic hernia mesh product has hit a "brick wall," according to CFO Charles Dockendorff, but does that mean the company is looking to move on from the product it dropped more than $80 million to acquire?
Do... |
| 01.11.2012 | The New Normal in Medical Device Exits | Boston Scientific may be leading the way in these types of deals, but serial acquirer Covidien is also dabbling in this trend, as witnessed by their acquisition of Maya Medical last spring. Maya, an Ardian look-alike with a catheter-based h... |
| 24.07.2012 | Chronic pain drug developer for cancer, lower back pain raises $3M | Location: Blue Bell, Pennsylvania
Industry: Pharmaceuticals
Solution/product: Its lead product is chronic pain treatment LevoCap, a proprietary once-a-day extended release dosage form of the opioid levorphanol. It is being presented as an a... |
| 26.06.2012 | Covidien closes $300 million Oridion deal | As expected, Covidien (NYSE:COV) closed its $300 million merger of Oridion Systems, an Israeli maker of pulse oximetry products.
In the deal, first announced in April, Covidien agreed to pay $23 per share for Oridion. Officials at the Mansf... |
| 22.03.2012 | Covidien grabs Newport Medical Instruments for $108 million | Covidien (NYSE:COV) continued to blaze the acquisitions trail, announcing a definitive agreement to acquire Newport Medical Instruments for $108 million.
Costa Mesa, Calif.-based Newport Medical is a ventilator systems maker with products o... |
| 21.11.2011 | Covidien nabs Barrx for $325 million | Acquisitions Roundup | Covidien (NYSE:COV) agreed to acquire Sunnyvale, Calif.-based device maker Barrx Medical Inc. for $325 million.
Barrx, a private company, specializes in minimally invasive radiofrequency ablation systems that target precancerous tissue in t... |
| 31.10.2011 | Four barriers stifling medical device innovation | “I think it will be,” he said. “But it will be very different.”
Augusti is the president of London based Smith & Nephew’s biologics division, which is located in Durham, North Carolina. Last Friday, Augusti spoke at the BioSciences Foru... |
| 27.10.2011 | HyperBranch raises $1M, tests new sealant for brain, spinal surgeries | HyperBranch’s investors include Durham venture capital firm The Aurora Funds. Jeff Clark, a managing director at Aurora, is HyperBranch’s chief operating officer. HyperBranch is led by President and CEO John Conn, a medical device industry ... |
| 16.08.2011 | Covidien lands $1.5 billion credit facility | Deals roundup | Covidien Plc. (NYSE:COV) announced a new agreement for a five year $1.5 billion senior unsecured revolving credit facility, secured through subsidiary Covidien International Finance S.A.
The new agreement replaces a prior five-year senior c... |
| 11.08.2011 | Covidien launches $2 billion stock repurchase program | Covidien Plc.’s (NYSE:COV) board of directors approved a $2 billion stock repurchase program today.
"The board’s approval of this share repurchase program reflects its confidence in the continued growth of Covidien’s business, our sust... |
| 11.08.2011 | Covidien announces $2 billion stock repurchase program | Listen to our recent interview with Covidien CEO Joe Almeida
“We remain committed to maintaining a strong balance sheet, but have no intention of accumulating cash. We will opportunistically look to return excess cash to shareholders, while... |
| 18.07.2011 | Diabetes glucose monitor company eyes $2.5 million raise, would leave Ohio | DIRAmed is one of several companies developing a diabetes glucose monitor to allow diabetics to check blood-sugar levels without drawing blood or pricking the skin. By making the process easier and less painful, a noninvasive meter could gr... |
| 27.06.2011 | Alzheimer’s disease drug company Curaxis shuffles management, board | Curaxis’s focus is on developing new treatments for Alzheimer’s disease. Alzheimer’s Disease International estimates that there are 35.6 million people worldwide with dementia. The group projects that that number will increase to 115.4 mill... |
| 23.11.2010 | DIRAmed aims for noninvasive glucose monitoring market | A small Columbus, Ohio, company is hoping to develop a blood glucose monitor for diabetics who are sick of pricking their skin to check their sugar levels.
DIRAmed LLC is one of several companies looking to cash in on what’s shaping up to b... |
| 23.11.2010 | Columbus firm raising funds for noninvasive blood glucose meter | “We don’t want to draw blood, and we don’t want to break the skin,” said CEO Will Shain, summarizing the company’s vision.
DIRAmed’s technology is based on Raman spectroscopy, which measures the scattering of light to help in molecular anal... |
| 02.06.2010 | Low valuations favor strategic buyers | By Thomas Lee
Given Wall Street’s turmoil of late, it’s not too surprising that buyers would search for bargains, especially struggling medical device companies with promising technology and awful balance sheets. Case in point: Medtronic In... |
| 02.06.2010 | ev3 latest Minnesotan medical technology company to cash out | Promoted
Covid-19’s terrible toll on diabetes patients. What can be done?
The public health crisis has undermined the economy and made people with chronic conditions more vulnerable and stressed. Learn more with a new report from Omada Heal... |
| 27.04.2010 | Sinusitis-device firm Entellus Medical hires new CEO | Farley joined VNUS, which developed a catheter-based treatment for venous insufficiency, in 1995 as its first employee. During his time as CEO, the company went public in 2004 and was acquired last year for $440 million by medical-products ... |
| 13.04.2010 | Q&A: Hemosphere CEO Doris Engibous | The company’s device, called the HeRo, was approved by the Food and Drug Administration in 2008. The device is made of a tube and a graft that are implanted under a patient’s skin to allow arterial access. Hemosphere recently hit a major mi... |
| 12.02.2010 | MedCity News Q&A: SpineMatrix CEO Bill Christy | By Mary Vanac
COPLEY TOWNSHIP, Ohio — Medical device company veteran William “Bill” Christy took the CEO’s spot at SpineMatrix Inc. in December.
SpineMatrix is the early stage company in the Akron, Ohio, area that has developed a diagnostic... |
| 21.12.2009 | SpineMatrix picks new CEO: Medical device industry veteran William ‘Bill’ Christy | During his career, Chrisy also served as founder and CEO of Ortheon Medical LLC, a company that focused on orthopedic tendon repair; founder and CEO of ESD Medical LLC, a developer of tubal ligation products, which was sold to U.S. Surgical... |
| 08.11.2007 | Life sciences briefing: Thursday, Nov. 8, 2007 | Featured companies: Formac Pharmaceuticals, Pradama, Protein Sciences, SantoSolve, Scandius BioMedical
UPDATED: Expanded items on Protein Sciences, SantoSolve, Scandius and Pradama.
Vaccine maker Protein Sciences gets $1M — Protein Sciences... |
| - | ev3 latest Minnesotan medical technology company to cash out | Given Wall Street’s turmoil of late, it’s not too surprising that buyers would search for bargains, especially struggling medical device companies with promising technology and awful balance sheets. Case in point: Medtronic Inc.’s (NYSE: MD... |
| - | HyperBranch raises $1M, tests new sealant for brain, spinal surgeries | Wound and surgical sealant company HyperBranch Medical Technology has developed a gel intended as a sealant for brain and spinal procedures. The company is in the midst of clinical testing to see if it works as well as a sealant from Covidi... |
| - | Chronic pain drug developer for cancer, lower back pain raises $3M | Company name: Relmada Therapeutics
Location: Blue Bell, Pennsylvania
Industry: Pharmaceuticals
Solution/product: Its lead product is chronic pain treatment LevoCap, a proprietary once-a-day extended release dosage form of the opioid levorph... |
| - | Are healthcare accelerators producing stronger startups? | There’s an interesting trend I’ve noticed with at least one healthcare accelerator I have been tracking. The members of the startups for the most part have increasingly more industry experience and seem more adept at finding pain points and... |
| - | Covidien makes wearables acquisition with Zephyr Technology deal | Covidien, the medical device manufacturer, has acquired Zephyr Technology Corp. for an undisclosed amount. Rhonda Luniak, a vice president of communications at Covidien, confirmed the deal, originally reported by MobiHealthNews.
Luniak told... |
| - | Columbus firm raising funds for noninvasive blood glucose meter | A small Columbus, Ohio, company is hoping to develop a blood glucose monitor for diabetics who are sick of pricking their skin to check their sugar levels.
DIRAmed LLC is one of several companies looking to cash in on what’s certain to be a... |
| - | Four barriers stifling medical device innovation | Smith & Nephew (NYSE:SNN) executive Mark Augusti takes time to occasionally talk to students about his experience in medical devices and his thoughts on the industry.
Often he’s asked if the industry that he’s made his career will be a ... |
| - | Still in the renal denervation space? Startups, consider adaptive trial design, CRO says | After Medtronic‘s (MDT) January announcement it’s halting renal denervation trials and BSX and Covidien following suit, the medical blogosphere erupted, proclaiming the “fall” of renal denervation. It seems to be more than a little prematur... |
| - | Diabetes glucose monitor company eyes $2.5 million raise, would leave Ohio | A company that’s developing a noninvasive blood glucose monitoring system for diabetics is hoping to raise $2.5 million to boost its staff and test its device.
And Columbus, Ohio-based DIRAmed said it would be willing to move out of the sta... |
| - | The New Normal in Medical Device Exits | The good news for emerging med-tech companies is that the M&A market remains active, with the big guys still needing to look outside for innovation. The nature of these exits, though, is changing. Historically, cash upfront deals with f... |
| - | Alzheimer’s disease drug company Curaxis shuffles management, board | Alzheimer’s disease drug development company Curaxis Pharmaceutical (OTC:CURX) is overhauling its operations with a swap out of both the management team and the board of directors.
Taking over as chairman of Curaxis’s board and interim CEO ... |
| - | SpineMatrix picks new CEO: Medical device industry veteran William ‘Bill’ Christy | Updated 5:16 p.m.
COPLEY TOWNSHIP, Ohio — SpineMatrix Inc., developer of a device that diagnoses the source of lower back pain in a unique way, has hired medical device industry veteran William “Bill” Christy as its chief executive officer.... |
| - | Sub-Saharan Africa: ‘perhaps the next frontier’ for medical device industry, says Covidien CEO | Covidien President and CEO Joe Almeida said in a little more than a decade, sub-Saharan Africa could be the big opportunity for medical device companies’ solution investments.
“It is a 10- or 15-year play. . . . The middle class will rise a... |
| - | Q&A: Hemosphere CEO Doris Engibous | After more than 20 years in corporate America, Doris Engibous says she was “big-companied out.”
So the medical technology veteran jumped at the opportunity to move from California to Minnesota six years ago to become a first-time CEO for He... |
| - | Value, VCs and international markets: One industry leader’s answers on where medtech fits in | Medtech Women will focus on value in healthcare at its annual Vision conference on Sept. 10 in Menlo Park, Calif. According to the organization’s website, the group brings together medtech’s “business leaders, financial investors, researche... |
| - | Sinusitis-device firm Entellus Medical hires new CEO | Entellus Medical Inc., which is developing a less-invasive therapy to treat chronic sinusitis, has hired a new chief executive.
Brian Farley, who has served on the company’s board since 2008 and previously led VNUS Medical Technologies Inc.... |
| - | These 8 digital health M&A deals stood out in 2014 | If you take a look at the 40 mergers and acquisitions in digital health this year, many were by or for startups, according to a StartUp Health report published this month. It shows that these companies are maturing and seek tools and produc... |
